Table 1 Baseline characteristics of hospitalized Covid-19 patients included in the study across SDI (Social Deprivation Index) quintiles.
From: Influence of social deprivation index on in-hospital outcomes of COVID-19
Overall (N = 30,012) | Social Deprivation Index (SDI) quintiles | ||||||
|---|---|---|---|---|---|---|---|
1 (N = 5098) | 2 (N = 1082) | 3 (N = 1590) | 4 (N = 1586) | 5 (N = 20,656) | P-Value | ||
Demographics | |||||||
Race, No. (%) | 0.007 | ||||||
White | 8490 (30.8) | 2035 (46.7) | 658 (63.0) | 827 (54.7) | 664 (44.8) | 4306 (22.5) | |
Ethnicity, No. (%) | < 0.001 | ||||||
Hispanic | 10,920 (41.0) | 1899 (45.0) | 152 (15.6) | 301 (21.7) | 316 (23.1) | 8252 (44.1) | |
Age, No. (%), y | 0.038 | ||||||
> 64 | 12,263 (40.9) | 2192 (43.0) | 439 (40.6) | 652 (41.0) | 643 (40.5) | 8337 (40.4) | |
45–64 | 9992 (33.3) | 1622 (31.8) | 372 (34.4) | 538 (33.8) | 511 (32.2) | 6949 (33.6) | |
25–44 | 6692 (22.3) | 1114 (21.9) | 233 (21.5) | 351 (22.1) | 388 (24.5) | 4606 (22.3) | |
18–24 | 1065 (3.6) | 170 (3.3) | 38 (3.5) | 49 (3.1) | 44 (2.8) | 764 (3.7) | |
Male, No. (%) | 15,247 (50.8) | 2452 (48.1) | 570 (52.7) | 863 (54.3) | 857 (54.0) | 10,505 (50.9) | < 0.001 |
Time, median (IQR) | |||||||
Weeks since March 1, 2020, | 9.3 (4.7,41.7) | 13.4 (5.1,42.1) | 33.7 (5.3,43.1) | 10.4 (4.7,42.2) | 9.9 (4.9,42.0) | 8.6 (4.6,41.3) | |
Vital signs at admission (Median (IQR) | |||||||
Systolic blood pressure | 126 (113,140) | 124 (112,139) | 126 (114,140) | 125 (113,141) | 126 (115,140) | 126 (113,140) | 0.016 |
Diastolic blood pressure | 74 (66,83) | 75 (68,83) | 77 (69,84) | 75 (66,83) | 76 (66,84) | 74 (65,82) | < 0.001 |
BMI | 28 (25,33) | 28 (24,32) | 29 (25,33) | 27 (24,32) | 28 (24,32) | 28 (25,33) | < 0.001 |
In-hospital Outcomes, No. (%) | |||||||
Intubation | 2902 (9.7) | 496 (9.7) | 84 (7.8) | 130 (8.2) | 132 (8.3) | 2060 (10.0) | 0.007 |
Mortality | 3554 (11.8) | 488 (9.6) | 88 (8.1) | 142 (8.9) | 156 (9.8) | 2680 (13.0) | < 0.001 |
Comorbidities, No. (%) | |||||||
Cancer | 5909 (19.7) | 910 (17.9) | 209 (19.3) | 329 (20.7) | 305 (19.2) | 4156 (20.1) | 0.005 |
Asthma | 4696 (15.6) | 564 (11.1) | 122 (11.3) | 218 (13.7) | 188 (11.9) | 3604 (17.4) | < 0.001 |
COPD | 4019 (13.4) | 381 (7.5) | 113 (10.4) | 210 (13.2) | 214 (13.5) | 3101 (15.0) | < 0.001 |
CAD | 7544 (25.1) | 859 (16.8) | 285 (26.3) | 477 (30.0) | 440 (27.7) | 5483 (26.5) | < 0.001 |
Heart failure | 4198 (14.0) | 534 (10.5) | 114 (10.5) | 197 (12.4) | 194 (12.2) | 3159 (15.3) | < 0.001 |
Diabetes | 9889 (33.0) | 1077 (21.1) | 286 (26.4) | 425 (26.7) | 466 (29.4) | 7635 (37.0) | < 0.001 |
Hyperlipidemia | 11,580 (38.6) | 1312 (25.7) | 425 (39.3) | 659 (41.4) | 616 (38.8) | 8568 (41.5) | < 0.001 |
Hypertension | 16,084 (53.6) | 2016 (39.5) | 553 (51.1) | 819 (51.5) | 825 (52.0) | 11,871 (57.5) | < 0.001 |
